In a special meeting Aug. 11, shareholders of CardioDynamics approved the company’s merger with hand-carried ultrasound pioneer SonoSite.
CardioDynamics set to join SonoSite
In a special meeting Aug. 11, shareholders of CardioDynamics approved the company’s merger with hand-carried ultrasound pioneer SonoSite. Under the $10 million cash deal, they will receive $1.35 per share, representing a 69% premium over the closing share price on June 8, 2009, the day before the definitive merger agreement was announced. The shareholder vote clears the way for CardioDynamics, which makes the BioZ impedance cardiography technology, to join SonoSite as a wholly owned subsidiary. The technology helps diagnose and assess high blood pressure and ventricular function.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.